Thet Thet Lin
机构: Assistant Lecturer, Coventry University
每年引用次数
引用次数
引用: 1,338
H-指数: 12
I10-指数 : 12
出版物: 14
Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease.
Thet Thet Lin , Kevin Norris , Nicole H. Heppel , Guy Pratt
British Journal of Haematology 167 ( 2) 214 -223
65
2014
CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL
Aneela Majid , Thet Thet Lin , Giles Best , Keith Fishlock
Leukemia Research 35 ( 6) 750 -756
50
2011
Defining the prognosis of early stage chronic lymphocytic leukaemia patients.
Chris Pepper , Aneela Majid , Thet Thet Lin , Saman Hewamana
British Journal of Haematology 156 ( 4) 499 -507
42
2012
Highly purified CD38+ sub-populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38- sub-populations derived from the same chronic lymphocytic leukaemia patient
Thet Thet Lin , Saman Hewamana , Rachel Ward , Hannah Taylor
British Journal of Haematology 142 ( 4) 595 -605
14
2008
Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia
Saman Hewamana , Thet Thet Lin , Clare Rowntree , Kamaraj Karunanithi
Journal of Clinical Oncology 27 ( 5) 763 -769
49
2009
Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis
Thet Thet Lin , Boitelo T. Letsolo , Rhiannon E. Jones , Jan Rowson
Blood 116 ( 11) 1899 -1907
129
2010
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
Chris Pepper , Thet Thet Lin , Guy Pratt , Saman Hewamana
Blood 112 ( 9) 3807 -3817
202
2008
The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
Saman Hewamana , Suhair Alghazal , Thet Thet Lin , Matthew Clement
Blood 111 ( 9) 4681 -4689
143
2008
The novel nuclear factor-κB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine
Saman Hewamana , Thet Thet Lin , Chris Jenkins , Alan K Burnett
Clinical Cancer Research 14 ( 24) 8102 -8111
60
2008
Highly purified CD38+ and CD38- sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin.
C Pepper , R Ward , T T Lin , P Brennan
Leukemia 21 ( 4) 687 -696
51
2007
Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage
B Britt-Compton , T T Lin , G Ahmed , V Weston
Leukemia 26 ( 4) 826 -830
32
2012
Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2.
C. Pepper , J. G. Mahdi , A. G. S. Buggins , S. Hewamana
Cell Proliferation 44 ( 4) 380 -390
26
2011
The NF-kappaB subunit, Rel A, is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukaemia and represents a promising therapeutic target: 321
S Hewamana , T Lin , M Clement , S Alghazal
British Journal of Haematology 141 118 -119
2008
CD38 (+) sub-clones exhibit increased proliferative activity but similar proliferative histories when compared with CD38 (-) sub-clones derived from the same CLL patient
TT Lin , R Hambly , S Hewamana , G Pratt
BRITISH JOURNAL OF HAEMATOLOGY 137 57 -58
2007